XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.21.1

Disaggregation of Revenues and Concentration Risk | 3 Months Ended
--- | ---
Mar. 31, 2021
Risks and Uncertainties [Abstract] |
Disaggregation of Revenues and Concentration Risk | 13. Disaggregation of Revenues and Concentration Risk The following table presents the percentage of consolidated revenues generated by unaffiliated customers that individually represent greater than ten percent of consolidated revenues:
|  | Three Months Ended March 31, |
|  | 2021 |  |  | 2020 |
Medicare for DetermaRx™ |  |  | 27% |  |  |  | -% |
Medicare Advantage for DetermaRx™ |  |  | 27% |  |  |  | - |
Pharma Services Company A |  |  | 20% |  |  |  | * |
Pharma Services Company B |  |  | 15% |  |  |  | * |
* | Less than 10%
The following table presents the percentage of consolidated revenues attributable to products or services classes that represent greater than ten percent of consolidated revenues:
|  | Three Months Ended March 31, |
|  | 2021 |  |  | 2020 |
DetermaRx™ |  |  | 54% |  |  |  | 10% |
Pharma Services |  |  | 46% |  |  |  | 90% |
Total |  |  | 100% |  |  |  | 100% |
The following table presents the percentage of consolidated revenues attributable to geographical locations:
|  | Three Months Ended March 31, |
|  | 2021 |  |  | 2020 |
United States |  |  | 57% |  |  |  | 95% |
Outside of the United States – Pharma Services |  |  | 43% |  |  |  | 5% |
Total |  |  | 100% |  |  |  | 100% |
The following table presents accounts receivable, as a percentage of total consolidated accounts receivables, from third-party payers and other customers that provided in excess of 10% of Oncocyte’s total accounts receivable.
|  | March 31, 2021 |  |  | December 31, 2020 |
Pharma Services Company A |  |  | 24% |  |  |  | 35% |
Medicare for DetermaRx™ |  |  | 16% |  |  |  | 45% |
Pharma Services Company B |  |  | 18% |  |  |  | - |
Medicare Advantage for DetermaRx™ |  |  | 38% |  |  |  | - |

X
- Definition Disaggregation of revenues and concentration risk [Text Block] + References No definition available. + Details
Name: | OCX_DisaggregationOfRevenuesAndConcentrationRiskTextBlock
Namespace Prefix: | OCX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration